Erika Petersen
Professor
Also affiliated: Centre National de la Recherche Scientifique (2010); University of Minnesota (2015); Queen Mary University of London (2010); Medical University of Graz (2010); Medical College of Wisconsin (2018–2019); Queen's University (2025); Instituto Cajal (2010); University of Arkansas Medical Center (2023–2026); Sobell House (2010); Oxford University Press (United Kingdom) (2020); Rigshospitalet (1979); Western Reserve Hospital (2015); Medtronic (Ireland) (2023); United States Army (1991); Medtronic (United States) (2023); Queens University (2025); Arkansas State Hospital (2014); Boston Scientific (Netherlands) (2023); Leitat Technological Center (2010); National Hospital for Neurology and Neurosurgery (2010); Kingston Health Sciences Centre (2025); Arkansas Department of Agriculture (2024); International Neuromodulation Society (2020); Arkansas Department of Health (2026); University College London (2010–2011); Credit Suisse (Switzerland) (2014); The University of Texas at Austin (2010); Accreditation Council for Graduate Medical Education (2014); The University of Texas Southwestern Medical Center (2010); The Hague University of Applied Sciences (2014); University of Tampa (2020–2023); Stanford University (2023)
Faculty Researcher
Neurosurgery, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dr. Erika Petersen's research focuses on the development of novel devices, indications, and methodologies for treating chronic pain through neuromodulation. She investigates new applications for deep brain stimulation and other neuromodulation techniques, collaborating with specialists in interventional pain, neuroradiology, neurology, and psychiatry.
Dr. Petersen's clinical practice encompasses neuromodulation for movement disorders, spasticity, and chronic pain, including surgical procedures and stereotactic radiosurgery. Her work has resulted in publications examining the efficacy of high-frequency spinal cord stimulation for conditions such as painful diabetic neuropathy and refractory back pain. She also contributes to guidelines and definitions for assessing treatment outcomes in spinal cord stimulation therapy.
With an h-index of 30, over 200 publications, and more than 3,200 citations, Dr. Petersen is recognized as a highly cited researcher. She holds leadership positions within the Department of Neurosurgery at the University of Arkansas for Medical Sciences, including directing the Section of Functional and Restorative Neurosurgery, serving as Vice-Chair for Education, and directing the neurosurgery residency program. Her academic background includes undergraduate studies at Princeton University and a medical degree from the University of North Carolina at Chapel Hill, followed by neurosurgery training at the University of Texas Southwestern and a fellowship in deep brain stimulation at the National Hospital for Neurology and Neurosurgery in London.
Research Overview
Dr. Petersen directs the Section of Functional and Restorative Neurosurgery at UAMS Medical Center. She is a professor in the Department of Neurosurgery at UAMS, Vice-Chair for Education, and program director for the neurosurgery residency. Dr. Petersen is a board certified neurosurgeon whose clinical practice focuses on neuromodulation, treating movement disorders, spasticity, and chronic pain through surgical procedures and stereotactic radiosurgery. Dr. Petersen's research interests focus on developing new devices, indications, and methods for treating chronic pain using neuromodulation. Her collaborations with colleagues in interventional pain, neuroradiology, neurology and psychiatry are aimed toward identifying new applications for the use of deep brain stimulation and neuromodulation for pain. Dr. Petersen completed her undergraduate education at Princeton University and received her medical degree from the University of North Carolina at Chapel Hill. She trained in neurosurgery at the University of Texas Southwestern with a fellowship in deep brain stimulation at the National Hospital for Neurology and Neurosurgery in London. Dr. Petersen has served on the Joint Section on Pain of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) and the CNS Scientific Programming Committee and sits on the Executive Board of the American Society of Pain and Neuroscience, where she is president. She serves as associate editor of stereotactic and functional neurosurgery for Operative Neurosurgery, section editor for the Journal of Pain Research, and on the editorial board of Neuromodulation and Neurosurgery, and contributes as a reviewer for several other journals. Dr. Petersen lectures frequently at national and international meetings on neuromodulation for pain, emerging considerations and uses of neuromodulation, chronic pain management and deep brain stimulation. She has authored numerous articles and book chapters related to stereotactic and functional neurosurgery and neuroscience.
Metrics
- h-index: 30
- Publications: 200
- Citations: 3,279
Selected Publications
-
Correction: Next‑Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience (2026)
-
Next-Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience (2026)
-
O012 SCS FREQUENCY AND PULSE WIDTH: INSIGHTS ON ECAP MORPHOLOGY AND NEURAL ACTIVATION (2026)
-
Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study (2025)
-
Evaluating pain and neurological function with high frequency 10 kHz spinal cord stimulation in the treatment of painful diabetic neuropathy: design of a multicentre, randomised controlled trial (PDN-Sensory) (2025)
-
Author's Response to Letter to the Editor Regarding “Long‐Term Efficacy of 10 <scp>kHz</scp> Spinal Cord Stimulation in Managing Painful Diabetic Neuropathy: A Post‐Study Survey” (2025)
-
First Objective Evidence Characterizing Differences in Cervical and Thoracic Spinal Cord Neurophysiology Using ECAP-Controlled Closed-Loop Technology (2025)
-
Technical and Clinical Overview: Spinal Cord Stimulation (2025)
-
ID# 1905850 Next Generation ECAP Detector For Signal Processing Using Dose-Controlled Closed-Loop SCS (2025)
-
ID# 1907171 Daily opioid use and Side Effects in Nonsurgical back pain patients treated with 10kHz SCS (2025)
-
ID# 1901157 Using SCS to treat chronic back pain patients ineligible for surgery: A US Delphi consensus (2025)
-
ID# 1907019 Beyond Pain: RCT Design to evaluate 10kHz SCS for sensory improvement in painful diabetic neuropathy (2025)
-
ID# 1907212 Walking Speed is Improved in Nonsurgical Back Pain Patients Treated with 10kHz Spinal Cord Stimulation (2025)
-
ID# 1906098 ECAP Study Premiere: Real-World IDE Study Showing Relationship between Physiologic ECAP Biomarkers and Pain Outcomes (2025)
-
Significant pain reduction in refractory post-mastectomy pain syndrome with closed-loop spinal cord stimulation: illustrative cases. (2025)
Grants & Funding
As listed on this researcher's institutional profile.
- Neural Enabled Prosthesis for Upper Limb Amputees (IRB 274358) NIH/Nat. Inst. of Biomedical Imaging & Bioengineering via University of Arkansas at Fayetteville Principal Investigator
- 274358 DOD - Neural Enabled Prosthesis for Upper Limb Amputees US Department of Defense via University of Arkansas at Fayetteville Principal Investigator
Collaboration Network
Top Collaborators
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain
- Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial
- Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
Showing 5 of 22 shared publications
- Persistent Spinal Pain Syndrome: A Proposal for Failed Back Surgery Syndrome and ICD-11
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation
- Best Practice Guidelines on the Diagnosis and Treatment of Vertebrogenic Pain with Basivertebral Nerve Ablation from the American Society of Pain and Neuroscience
- Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)
Showing 5 of 17 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
Showing 5 of 14 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
Showing 5 of 14 shared publications
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial
- Remote Management of Spinal Cord Stimulation Devices for Chronic Pain: Expert Recommendations on Best Practices for Proper Utilization and Future Considerations
- Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation
- Durable responses at 24 months with high-frequency spinal cord stimulation for nonsurgical refractory back pain
Showing 5 of 12 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
Showing 5 of 11 shared publications
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation
- Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)
- First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulation
- Remote Management of Spinal Cord Stimulation Devices for Chronic Pain: Expert Recommendations on Best Practices for Proper Utilization and Future Considerations
Showing 5 of 11 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
- Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation
Showing 5 of 10 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
Showing 5 of 9 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
Showing 5 of 9 shared publications
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation
- Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation
- Impact of Long-Term Evoked Compound Action Potential Controlled Closed-Loop Spinal Cord Stimulation on Sleep Quality in Patients With Chronic Pain: An EVOKE Randomized Controlled Trial Study Subanalysis
- Durable multimodal and holistic response for physiologic closed-loop spinal cord stimulation supported by objective evidence from the EVOKE double-blind randomized controlled trial
Showing 5 of 9 shared publications
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial
- High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial
- High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy
Showing 5 of 8 shared publications
- The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)
- A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET
- Social Media and Professional Conduct (SMART): Best Practice Guidelines from the American Society of Pain and Neuroscience (ASPN)
Showing 5 of 8 shared publications
- The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain
- Best Practice Guidelines on the Diagnosis and Treatment of Vertebrogenic Pain with Basivertebral Nerve Ablation from the American Society of Pain and Neuroscience
- Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)
- A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET
- Social Media and Professional Conduct (SMART): Best Practice Guidelines from the American Society of Pain and Neuroscience (ASPN)
Showing 5 of 8 shared publications
- ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
- Remote Management of Spinal Cord Stimulation Devices for Chronic Pain: Expert Recommendations on Best Practices for Proper Utilization and Future Considerations
- Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation
- Durable multimodal and holistic response for physiologic closed-loop spinal cord stimulation supported by objective evidence from the EVOKE double-blind randomized controlled trial
- The Neurostimulation Appropriateness Consensus Committee (NACC)®: Recommendations for Spinal Cord Stimulation Long-Term Outcome Optimization and Salvage Therapy
Showing 5 of 8 shared publications
Similar Researchers
Based on overlapping research topics